Back to
Allspring Global Investments Holdings, LLC
AMLXShowing 1 of 11 quarters
Position history for
Allspring Global Investments Holdings, LLC's holdings in AMYLYX PHARMACEUTICALS INC
No. Allspring Global Investments exited its AMLX (Amylyx Pharmaceuticals) position in Q3 2024. Its Q2 2024 13F listed 28,785 shares worth $54,691. Allspring Global Investments already held AMLX in its Q1 2022 13F, the earliest on record, and held it in 10 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of AMLX: FMR LLC, VIKING GLOBAL INVESTORS LP